Therapy | Page 169 of 190 | SpiritIndia.com

Cancer :: First Head n Neck Cancer Treatment with Erbitux

The Food and Drug Administration (FDA) announced the approval of Erbitux (cetuximab) for use in combination with radiation therapy to treat patients with squamous cell cancer of the head and neck (SCCHN) that can not be removed by surgery (unresectable SCCHN). This is the first drug approved for head and neck cancer that has shown a survival benefit in this population. Erbitux was also approved today for use alone (monotherapy) to treat patients whose head and neck cancer has spread (metastasized) despite the use of standard chemotherapy.

Fungal Infection :: New Treatment for Fungal Infections

The Food and Drug Administration approved Eraxis (anidulafungin) to treat certain infections caused by Candida, a yeast-like fungus that can cause serious infections in hospitalized patients or patients with compromised immune systems.

Cancer :: Initiative to Improve Cancer Therapy

The Food and Drug Administration (FDA), the National Cancer Institute (NCI), part of the National Institutes of Health, and the Centers for Medicare & Medicaid Services (CMS) today announced the Oncology Biomarker Qualification Initiative (OBQI) — an agreement to collaborate on improving the development of cancer therapies and the outcomes for cancer patients through biomarker development and evaluation.

Health :: The Power of Simplicity in Holistic Living

What does it take to live life holistically? It definitely does not require a degree from well known university, a high paying job or huge bank balance. Holistic living has nothing to do with all that!

Erectile Dysfunction :: Treatment just got better for erectile dysfunction

From the time a woman is seven years old till she dies of old age, she is ready for action, and competent. As competent as the candlestick to receive the candle. But man is only briefly competent…After fifty his performance is of poor quality; the intervals between are wide, and its satisfactions of no great quality to either party; whereas his great-grandmother is as good as new. – Mark Twain in Letters from the Earth

Sclerotherapy :: Cosmetic surgery for spider and varicose veins

The standard treatment for spider and varicose veins is Sclerotherapy, which involves injecting a chemical (usually salt-water, or saline) solution into the blood vessel, which then collapses and is absorbed by the body.

Cosmetic Surgery :: Cheek implants n silicone lip augmentation -Facial Beauty

Today, we live in a culture totally youth-oriented. Aspiration to get younger, healthier and beautiful (or handsome) is growing. Face is the most remarkable feature of a human body. We know someone by face as much as we know by one?s name and fame. But with age we loose the youthfulness and face is the striking human future that shows our loss in terms of health and beauty, by developing loose skins, fine lines and bags around the eyes.

Skin Care :: What is Chloasma or melasma

Chloasma, or melasma or the mask of pregnancy when present in pregnant women is a tan or dark facial skin discoloration. Although it can affect anyone, chloasma (melasma) is particularly common in women, especially pregnant women and those who are taking oral contraceptives or hormone replacement therapy medications.

Constipation :: Amitiza, lubiprostone for treating chronic constipation

The FDA approved Amitiza (lubiprostone), the first drug of its chemical type, for the treatment of chronic constipation in the adult population where there is no known cause for the condition. The product will be available as capsules for use by adults to treat idiopathic constipation cases not caused by other diseases or by use of medications.

Diabetes :: Exubera – Inhaled Insulin Combination for Treatment of Diabetes

There is a new, potential alternative for many of the more than 5 million Americans who take insulin injections, with the Food and Drug Administration’s approval today of the first ever inhaled insulin. Exubera, an inhaled powder form of recombinant human insulin (rDNA) for the treatment of adult patients with type 1 and type 2 diabetes, is the first new insulin delivery option introduced since the discovery of insulin in the 1920s.